Public Citizen Hits Eli Lilly For Not Disclosing Lobbying Expenses Ahead Of Shareholder Vote

By Maaisha Osman / May 3, 2024 at 5:40 PM
As a handful of key Senate Democrats and consumer advocates engage in a broader effort to get companies to disclose lobbying expenses, Public Citizen on Friday (May 3) blasted drug maker Eli Lilly for not making all its expenditures public in the run-up to its annual meeting next week where shareholders are slated to hold a vote demanding transparency. The shareholders suggest Lilly’s public statements, including that it supports lowering drug prices, may clash with the lobbying data it has...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.